Valve Regurgitation Research Articles

Residual or recurrent mitral regurgitation predicts mortality following transcatheter edge-to-edge mitral valve repair

ObjectiveAlthough regurgitant mitral valves can be repaired through surgical or transcatheter approaches, contemporary comparative outcomes are limited with the impact of residual and recurrent mitral regurgitation (MR) on clinical outcomes being poorly defined. We hypothesized that moderate (2+) or greater residual or recurrent (RR) MR—regardless of type of repair—predicts worse clinical outcomes. MethodsOur institutional experience of 660 consecutive patients undergoing mitral valve repair (2015-2021) consisting of 393 surgical mitral valve repair (SMVr) and 267 transcatheter edge-to-edge mitral valve repair (TEER) was studied. The echocardiographic impact of RRMR (2+) following both SMVr and TEER on death and reintervention was evaluated. ResultsPatients averaged 67.8 ± 14.2 years (SMVr = 63.8 ± 13.3 vs 73.6 ± 13.6, P < .0001) and 62.1% were male. Baseline clinical and demographic data were vastly different between the 2 groups. Residual or recurrent 2+ or greater MR developed in 25% (n = 68) of patients who received TEER compared with 6% (n = 25) of SMVr (P < .0001). Reintervention (9.3% vs 2.4%, P = .002) and death (37.9% vs 10.4%, P < .0001) rates at 3-years were greater among the TEER group versus SMVr group. Given the heterogeneity in baseline characteristics and difference in survival, each cohort was analyzed separately, stratified by RRMR, using multivariable modeling to identify predictors of repeat reintervention and death. There were too few events of RRMR in the SMVr cohort for evaluation. For the TEER subgroups, we observed greater long-term mortality, but not reintervention among those with RRMR., Hypertension was the strongest predictor of death and obesity was for reintervention. ConclusionsPatients undergoing SMVr and TEER are vastly different with respect to baseline patient characteristics and clinical outcomes, with patients who undergo TEER being much greater risk with poorer prognosis. Moderate or greater RRMR predicted worse long-term survival but not reintervention among patients who received TEER. Given the difference in survival among patients with RRMR following TEER, care must be taken to ensure that patients entering clinical trials and receiving TEER should have a high probability of achieving mild or less MR as seen in contemporary surgical results.

Cardiac Abnormalities in Patients With Severe Fever With Thrombocytopenia Syndrome: A Systematic Review

Abstract Since the identification of severe fever with thrombocytopenia syndrome virus (SFTSV) in 2010, there has been an increase in reported cases in China and other Asian countries. Cardiac abnormalities are highly prevalent in SFTS patients. We searched 5 Chinese and international databases for published SFTS articles and extracted patient characteristics, cardiac complications, electrocardiography findings, and imaging findings. Twenty-seven studies were identified, covering 1938 patients and 621 cardiac abnormalities. Arrhythmia was the most prevalent, reported in 24 studies and 525 cases, with a prevalence of 27.09%. The 2 major types of arrhythmias were bradycardia and atrial fibrillation. Heart failure was the second most prevalent abnormality, with 77 cases. Changes in the ST segment and T wave were the most common. Valve regurgitation, reduced ejection fraction, and pericardial effusion were also documented. We recommend that physicians pay close attention to newly onset arrhythmia and structural heart disease in SFTS patients.

Heart Sounds Classification Based on High‐Order Spectrogram and Multi‐Convolutional Neural Network after a New Screening Strategy

AbstractThis paper proposes a pre‐processing method for heart sound screening and extracts the high‐order spectral feature of phonocardiogram. Moreover, a multi‐convolutional neural network (mCNN) is constructed to achieve the classification of normal, aortic stenosis, mitral regurgitation, mitral stenosis, and mitral valve prolapse. First, the heart sound recordings are down‐sampled, denoised by wavelet transform, and normalized. Second, a new heart sound screening algorithm is proposed. The waveform of the heart sound recording is segmented and saved as an image which is performed by the gray‐scale processing to calculate the amplitude of the heart sound. The extremely noisy heart sound segments are screened out based on the amplitude information, and the remaining heart sound segments are spliced as pure heart sound recordings. After 50% superposition segmentation of the heart sound recordings, high‐order spectral features are extracted and image data are stored. Finally, a 34‐layer mCNN is specifically designed to boost the performance of heart sound classification through multi‐layer dimensionality reduction. Experimental results show that the proposed method has superior performance compared with the existing one. For the two‐category dataset, the accuracy with and without PCG screening is 97.99% and 99.42%, respectively. For the five‐category dataset, the average accuracy is 99%.

Outcomes of neo-aortic valve and root surgery late after arterial switch operation

BackgroundNeo-aortic root dilatation and valve regurgitation are emerging problems late after arterial switch operation (ASO). We sought to evaluate the prevalence and outcomes of neo-aortic root or valve reoperation after ASO. MethodsAll patients with biventricular circulation who underwent an ASO between 1983 and 2015 were included at a single institution. ResultsIn our cohort of 782 late ASO survivors, the median duration of follow-up was 18.1 years (interquartile range [IQR], 11.3-25.6 years). During follow-up, 47 patients (6.0%) underwent 60 reoperations on the neo-aortic valve/root. The first neo-aortic valve/root reoperation occurred at a median of 15.2 years (IQR, 7.8-18.4 years) after ASO. Operations included mechanical Bentall (31.9%; n = 15), aortic valve repair (25.5%; n = 12), mechanical aortic valve replacement (AVR) (21.3%; n = 10), valve-sparing root replacement (19.1%; n = 9), and the Ross procedure (2.1%; n = 1). There was 1 late death (2.1%). Multivariable predictors of neo-aortic valve/root reoperation were bicuspid valve (hazard ratio [HR], 4.8; 95% confidence interval [CI], 2.1-10.7; P < .001), Taussig-Bing anomaly (HR, 3.0; 95% CI, 1.2-7.4; P < .02), previous pulmonary artery band (HR, 2.8; 95% CI, 1.2-6.3; P < .01) and left ventricular outflow tract obstruction before ASO (HR, 2.4; 95% CI, 1.0-5.8; P < .04). Freedom from neo-aortic valve or root reoperation was 98.0% (95% CI, 96.7%-98.8%) at 10 years, 93.3% (95% CI, 90.8%-95.2%) at 20 years, and 88.5% (95% CI, 84.1%-91.8%) at 30 years after ASO. Among the 47 patients who underwent neo-aortic reoperation, freedom from AVR was 82.3% (95% CI, 67.7%-90.7%) at 10 years, 58.0% (95% CI, 41.8%-71.2%) at 20 years, and 43.2% (95% CI, 27.0%-58.3%) at 25 years after ASO. ConclusionsThe need for neo-aortic valve or root reoperation surpasses 10% by 30 years post-ASO. Evolving understanding of the mechanisms of neo-aortic valve insufficiency and techniques of neo-aortic valve repair may decrease the need for AVR.

Heyde-like syndrome occurring for the first time following aortic valve replacement with a bioprosthesis: a case report

BackgroundHeyde’s syndrome is known as a combination of gastrointestinal (GI) bleeding and aortic valve stenosis. However, there are no reports of an association between GI bleeding and bioprosthetic valve stenosis initially occurred after aortic valve replacement (AVR), even though there are several reports that GI bleeding due to native aortic valve stenosis disappeared after AVR, and GI bleeding recurred due to bioprosthetic valve stenosis or patient-prosthesis mismatch.Case presentationAn 80-year-old woman who was on hemodialysis for 13 years had undergone AVR with a bioprosthetic valve for aortic regurgitation 3 years prior. She was admitted with acute heart failure and anemia that required repeated blood transfusions. Capsule endoscopy revealed multiple active hemorrhages of the small intestine due to angiodysplasia. Echocardiography showed severe bioprosthetic valve stenosis in the aortic valve position as a result of structural valve deterioration (SVD). Because Heyde’s syndrome was strongly suspected even though gel electrophoresis analysis of von Willebrand factor multimers, the gold standard examination for the definitive diagnosis of Heyde’s syndrome, was not performed, a redo AVR with a new bioprosthetic valve was performed. After the second AVR, both the heart failure and anemia due to GI bleeding promptly improved.ConclusionsBioprosthetic valve stenosis due to SVD can bring GI bleeding just as in native aortic valve stenosis. Redo AVR is a promising treatment if the combination of GI bleeding and valve stenosis in the aortic valve position appears even after AVR.

A comprehensive mathematical model for cardiac perfusion

The aim of this paper is to introduce a new mathematical model that simulates myocardial blood perfusion that accounts for multiscale and multiphysics features. Our model incorporates cardiac electrophysiology, active and passive mechanics, hemodynamics, valve modeling, and a multicompartment Darcy model of perfusion. We consider a fully coupled electromechanical model of the left heart that provides input for a fully coupled Navier–Stokes–Darcy model for myocardial perfusion. The fluid dynamics problem is modeled in a left heart geometry that includes large epicardial coronaries, while the multicompartment Darcy model is set in a biventricular myocardium. Using a realistic and detailed cardiac geometry, our simulations demonstrate the biophysical fidelity of our model in describing cardiac perfusion. Specifically, we successfully validate the model reliability by comparing in-silico coronary flow rates and average myocardial blood flow with clinically established values ranges reported in relevant literature. Additionally, we investigate the impact of a regurgitant aortic valve on myocardial perfusion, and our results indicate a reduction in myocardial perfusion due to blood flow taken away by the left ventricle during diastole. To the best of our knowledge, our work represents the first instance where electromechanics, hemodynamics, and perfusion are integrated into a single computational framework.

The Development of a Permanent Implantable Spacer with the Function of Size Adjustability for Customized Treatment of Regurgitant Heart Valve Disease.

The Pivot Mandu is an innovative device featuring a leak-tight adjustable 3D balloon spacer, incorporating inner mesh support, an outer e-PTFE layer, and a compliant balloon in the middle layer with a specialized detachable system. To assess its feasibility, proof of concept was rigorously evaluated through bench testing and survival porcine animal experiments. The results demonstrated successful remote inflation of the balloon system, with the balloon spacer exhibiting sustained patent and functional integrity over an extended observation period of up to 6 months. A noteworthy feature of the newly designed 3D balloon spacer is its capability for easy size adjustment during procedures, enhancing its adaptability and practicality in clinical settings. This three-layered 3D balloon spacer, with its established long-term patency, exhibits highly encouraging outcomes that hold promise in overcoming the current limitations of spacer devices for heart valve diseases. Given the compelling results from preclinical investigations, the translation of the Pivot Mandu into human trials is strongly warranted.

Comparison on the efficacy of Chinese-made novel-designed mechanical-locked and elastic self-locked transcatheter edge-to-edge repair system in the treatment of patients with functional mitral regurgitation

Objective: To evaluate and compare the short-term efficacy of domestic mechanical-locked (Clip2Edge) and elastic self-locked (ValveClip) transcranial mitral valve edge-to-edge interventional repair (TEER) devices in the treatment of functional mitral regurgitant valves. Methods: In this retrospective non-randomized comparative study, patients underwent TEER procedure in Fuwai Yunnan Cardiovascular Disease Hospital from May 2022 to April 2023 for heart failure combined with moderate to severe or severe functional mitral valve were divided into Clip2Edge and ValveClip groups based on the TEER system used. Baseline, perioperative, and postoperative 30 d follow-up data were collected and compared between the two groups. The primary outcome was the success rate on the 30 d post operation, while secondary outcomes included immediate postoperative technical success rate and the incidence of all-cause mortality on the 30 d post operation, readmission rate of acute heart failure, cerebral infarction, severe bleeding, and other serious adverse events rates. Results: A total of 60 patients were enrolled, 34 patients were in the Clip2Edge group and 26 in the ValveClip group, mean age was (63.8±9.3) years, and 24 patients (40%) were female. There were no significant differences in baseline data of age, cardiac function, comorbidities, mitral regurgitation 4+(19(73%) vs. 29(85%)), the end-diastolic volume of left ventricle ((220.8±91.2) ml vs. (210.8±71.7) ml) between the two groups (all P>0.05). The technical success rate immediately after the procedure was 100%. There were no readmission of acute heart failure, death, cerebral infarction, severe bleeding, and other serious adverse events up to the 30 d follow-up. Device success rate was similar between the ValveClip group (24 cases (100%)) and the Clip2Edge group (27 cases (96%)) (P>0.05). Conclusion: Both types of novel domestic TEER devices are safe and feasible in treating patients with functional mitral regurgitation.

Patent foramen ovale in carcinoid heart disease: The potential role for and risks of percutaneous closure prior to cardiothoracic surgery.

Neuroendocrine tumours (NETs) are rare but once metastasised, can lead to the release of vasoactive substances into the systemic circulation, and the classical features of carcinoid syndrome (CS) such as flushing and diarrhoea. A consequence of CS is carcinoid heart disease (CHD) which primarily affects the right-sided heart valves and can eventually lead to right heart failure. In this cohort, tricuspid and/or pulmonary valve replacement provides symptomatic relief. A patent foramen ovale (PFO) in patients with CHD can lead to the shunting of oxygen deficient blood to the systemic circulation causing hypoxaemia and reduced exercise tolerance. Additionally, the haemodynamic changes caused by regurgitant right-sided heart valves can increase the patency of a PFO allowing the passage of vasoactive substances to the systemic circulation thereby affecting the left-sided heart valves. We present data on the incidence of PFO in patients referred for surgery at our centre, in which the standard approach is to close the defect at time of cardiothoracic surgery. In addition, we present a series of four cases that highlight how the option of percutaneous PFO closure prior to open valve surgery may reduce haemodynamic instability and open a window of opportunity to enhance preoperative status. Percutaneous PFO closure then acts as a bridge to definitive cardiothoracic surgery, although there are risks in such an approach.

Long-term outcomes of percutaneous closure of ventricular septal defects in children using different devices: A single centre experience from Egypt

BackgroundThe feasibility of percutaneous closure ventricular septal defects (VSD) in children has been previously proven. However, data on long-term outcomes are limited. We aim to evaluate the long-term outcome of our experience with percutaneous closure of VSD using various occluders.MethodsRetrospective institutional analysis of children who underwent transcatheter closure of perimembranous and muscular VSDs between September 2012 and February 2020. Patient demographics, procedural, and long-term follow-up data were comprehensively analyzed. Patients who lost to follow-up within two years post-procedure were excluded.ResultsWe identified 75 patients (54.7% males) with a median of 66 months (IQR, 46–96). The closure success rate at one year was 95.7%. Complete heart block was detected in two patients early post-procedure and resolved with steroids. The VSDs were perimembranous (52%), muscular (33.33%), and residual (14.67%). Implanted devices were Pfm Nit-Occlud LeˆVSD Coil (42.7%), HyperionTM VSD Muscular Occluder (28%), Amplatzer VSD muscular occluder (10.7%), Amplatzer Duct Occluder (14.7%), Occlutech Muscular VSD Occluder (2.7%), and Amplatzer Duct Occluder II (1.3%). No new arrhythmia or valve regurgitation was detected after two years post-procedure. Persisted complications on long-term follow-up included: residual shunting in 3(4%), mild tricuspid regurgitation in 2(2.7%), and aortic regurgitation in 2(2.7%), with one immediate post-catheterization mild aortic regurgitation worsened during follow-up, requiring surgical repair of VSD three years after device implantation. No deaths were reported.ConclusionLong-term outcomes of pediatric transcatheter VSD closure using different devices are satisfactory. Post-procedural adverse events are limited, but long-term surveillance is necessary to monitor their progression.

Machine learning‐based classification of multiple heart disorders from PCG signals

AbstractTimely and accurate detection and diagnosis of heart disorders is a significant problem in the medical community since the mortality rate is increasing. Pulsing of cardiac structures and blood turbulence creates heart sounds recorded and detected through Phonococardiogram (PCG). As a non‐invasive technique, PCG signals have a strong ability to be used for designing automatic classification of possible heart disorders. This paper presents an expert system design for the detection and classification of PCG signals for five classes, namely, healthy, aortic stenosis, mitral stenosis, mitral regurgitation, and mitral valve prolapse. In this work, a single‐channel PCG signal is first decomposed using Empirical Mode Decomposition (EMD) into different modes known as intrinsic mode functions (IMFs). Manual signal analysis is applied to identify the relevant IMFs to construct a preprocessed signal. We proposed an automated energy‐based signal reconstruction through IMFs. The proposed algorithms automatically identify the relevant IMFs and added them together to form a preprocessed signal. After preprocessing, the first nine features of Mel Frequency Cepstral Coefficients (MFCC) were computed and passed to several classification methods such as Fine Tree, Quadratic Discriminant, Kernel Naive Bayes, Support Vector Machines (SVM), Fine K‐Nearest Neighbours (Fine‐KNN), Ensemble Bagged Trees and Neural Network. The best performance of 99.3% accuracy was obtained via Fine‐KNN using 10‐fold cross‐validation. The proposed method was evaluated on a publicly available dataset of heart sounds. The proposed method demonstrated improved performance as compared to the existing state‐of‐the‐art methods.

Association of Interstage Monitoring Era and Likelihood of Hemodynamic Compromise at Intervention for Recoarctation Following the Norwood Operation.

Background Intensive monitoring has been associated with a lower death rate between the Norwood operation and superior cavopulmonary connection, possibly due to early identification and effective treatment of residual anatomic lesions like recoarctation before lasting harm occurs. Methods and Results Neonates undergoing a Norwood operation and receiving interstage care at a single center between January 1, 2005, and September 18, 2020, were studied. In those with recoarctation, we evaluated association of era ([1] preinterstage monitoring, [2] a transitional phase, [3] current era) and likelihood of hemodynamic compromise (progression to moderate or greater ventricular dysfunction/atrioventricular valve regurgitation, initiation/escalation of vasoactive/respiratory support, cardiac arrest preceding catheterization, or interstage death with recoarctation on autopsy). We also analyzed whether era was associated with technical success of transcatheter recoarctation interventions, major adverse events, and transplant-free survival. A total of 483 subjects were studied, with 22% (n=106) treated for recoarctation during the interstage period. Number of catheterizations per Norwood increased (P=0.005) over the interstage eras, with no significant change in the proportion of subjects with recoarctation (P=0.36). In parallel, there was a lower likelihood of hemodynamic compromise in subjects with recoarctation that was not statistically significant (P=0.06), with a significant difference in the proportion with ventricular dysfunction at intervention (P=0.002). Rates of technical success, procedural major adverse events, and transplant-free survival did not differ (P>0.05). Conclusions Periods with interstage monitoring were associated with increased referral for catheterization but also reduced likelihood of ventricular dysfunction (and a suggestion of lower likelihood of hemodynamic compromise) in subjects with recoarctation. Further study is needed to guide optimal interstage care of this vulnerable population.

Diffusion-weighted whole-body magnetic resonance imaging with background body signal suppression was useful in a patient with isolated myocardial abscess confined to the right atrial wall: a case report

BackgroundMyocardial abscess is often associated with infective endocarditis (IE), and isolated myocardial abscess without IE is rare. Echocardiography and computed tomography (CT) are often used to diagnose myocardial abscess; however, to the best of our knowledge, diffusion-weighted whole-body magnetic resonance imaging with background body signal suppression (DWIBS) has not been used. Here, we present a case of myocardial abscess without IE that was diagnosed using DWIBS.Case presentation: A 72-year-old Japanese man with a history of hypertension, dyslipidemia, and retinitis pigmentosa presented to our hospital with malaise and a fever lasting 10 days. Blood test results showed elevated inflammatory marker levels (white blood cell count 18,700/µL and C-reactive protein level 23.0 mg/dL). Infection was suspected; however, the source of the infection could not be identified. DWIBS, which was performed on day 7 of admission to determine the source of infection, showed a high signal surrounding the right wall, suggesting inflammation. Contrast-enhanced CT performed on day 1 of hospitalization revealed a low-density area in the same region; however, the pathological implications of this finding could not be determined. Based on DWIBS findings, we concluded that the condition presented as a myocardial abscess that was confined specifically to the right atrial wall. Three sets of blood cultures revealed negative findings, and echocardiography showed no vegetation or valve regurgitation. Therefore, the patient was diagnosed with an isolated myocardial abscess uncomplicated with IE. An electrocardiogram on admission showed no P waves, and the patient had a junctional rhythm. However, on day 20 of hospitalization, he developed a complete atrioventricular block. After complete myocardial abscess healing following antibiotic treatment was confirmed, the patient underwent pacemaker implantation. Ten months after surgery, the patient had no signs of infection recurrence.ConclusionsBased on history and physical examination alone, diagnosis of an isolated myocardial abscess can be challenging. In addition to CT and echocardiography, DWIBS might be helpful for the diagnosis of myocardial abscesses.

Impact of sex on severity assessment and cardiac remodeling in primary mitral regurgitation due to valve prolapse

Abstract Funding Acknowledgements Type of funding sources: None. Background It is well known that left ventricular(LV) dimensions are influenced by body size and sex. However, current guidelines for primary mitral regurgitation(MR) valve disease propose echocardiographic cut-off values for MR quantitative parameters (effective orifice regurgitant area(EROA), regurgitant volume(RegVol)) and left heart remodeling (LV end-systolic diameter[ESD], indexed LA volume[indLAV]) which are not sex-specific. Purpose Therefore we aimed at evaluating how MR severity and cardiac remodeling are influenced by sex. Methods We retrospectively evaluated 470 patients (27% women, median age 63 [IQR: 53–71] years) with chronic significant (at least moderate to severe) primary MR due to valve prolapse who underwent transthoracic echocardiographic(Echo) and cardiac magnetic resonance imaging(CMR) in 3 tertiary centers between 2005 and 2022. The relationship between MR quantification, cardiac remodeling and sex was evaluated. Results Women were older than men (p&amp;lt;0.001), had higher NYHA functional class (p = 0.035), larger Echo-indLAV (p = 0.003), higher right ventricle systolic peak pressure (p = 0.032), and more symptoms-triggered MV intervention (p = 0.029). However, both EROA (p&amp;lt;0.001), Echo-RegVol (p = 0.003) and CMR-RegVol (p&amp;lt;0.001) were lower in women than in men, while CMR regurgitant fraction(RegFrac) values were similar (p = 0.890). Abnormally increased CMR- (&amp;gt;upper limit bound of UK Biobank reference values) indexed LV end-diastolic(indLVEDV), end-systolic volume(indLVESV) and indLAV were observed in 55%, 29% and 82% of patients, respectively, without sex difference (p = 1, p = 0.9 and p = 0.5). The optimal cut-off values of MR EROA, Echo-RegVol and CMR-RegVol associated with enlarged indLVEDV were lower in women (40mm2, 60ml, 50ml) than in men (45mm2, 77ml, 62ml). The threshold of LVESD ≥40mm showed in women and men high specificity[Sp] (91%, 79%) but poor sensitivity[Se] (40%, 50%) to predict enlarged indLVESV. Accordingly, the best threshold of LVESD to predict enlarged indLVESV was slightly lower in women (35mm, Se=65%, Sp = 71%, AUC=0.72) than in men (37mm, Se=65%, Sp = 68%, AUC=0.72). Replacing absolute by indexed LVESD did not improve the predictive value. In contrast, the best threshold of Echo-indLAV associated with enlarged CMR-indLAV was lower in men (47ml/m2, Se=68%, Sp = 71%, AUC=0.76) than in women (56ml/m2, Se=70%, Sp = 71%, AUC=0.73). Conclusion Despite clear hallmarks of more advanced valve disease, women with primary MR have lower absolute mitral regurgitant volumes and lower ventricular volumes than men. Furthermore, cut-off values of mitral regurgitant volume, effective orifice regurgitant area and LV dimensions for predicting abnormal LV dilatation by CMR are lower in women than in men. Conversely, cut-off values of indexed LA volume by echo for predicting abnormal LA dilatation by CMR are lower in men than in women. Therefore, guideline-based criteria for grading MR and timing of intervention could be sex-specific.

CARD25: Development of a Minimally Invasive Single Port Pulsatile Ventricular Assist Device

Purpose: Our goal is to develop a compact, single port, pulsatile ventricular assist device (VAD) for total left ventricle (LV) support that only requires a minimally invasive single cannulation from apex to aorta. Methods: Standard diaphragm displacement pumps have 2 valved ports and inlet/outlet cannulas to alternate between blood infusion and withdrawal. By contrast, our compact single port pulsatile VAD consists of a valved single lumen cannula and a valveless single port diaphragm displacement pump. Via a small left thoracotomy, the valved single lumen cannula is inserted from apex to aorta (Fig). Four one-way inlet valves on the valved single lumen cannula wall allow blood withdrawal from LV, and a tri-leaflet outlet valve at the cannula tip allows blood delivery to aorta. The 28 Fr valved single lumen cannula prototype was made as one piece by polyurethane (PU) dip molding with memory alloy reinforcement. The two halves of the valveless single port diaphragm displacement pump prototype housing were made by polycarbonate vacuum thermoforming and assembled with a flexible PU membrane diaphragm in the middle to separate the blood and pneumatic chambers. This pump had a 60 cc stroke volume. A closed mock loop with 37% glycerin was used to mimic the LV-aortic valve-ascending aorta tract. Priming volume and reservoir height were adjusted to maintain 70 mm Hg diastolic aortic pressure and 16 mm Hg preload. Circuit flow and pressure in valved single lumen cannula were recorded. The catheter introducer with pressure transducer on tip was inserted through apex in adult sheep (n=5, 44-52 kg), with pressure wave form guiding tip into ascending aorta. The valved single lumen cannula slid along introducer through apex, crossing aortic valve, with its tip in ascending aorta. The valved single lumen cannula was connected to the single port diaphragm displacement pump. Pumping was increased for a normal cardiac output. The single port pulsatile VAD prototype performance was assessed for 6 hrs with hemodynamics/blood counts recorded. Results: The valved single lumen cannula and single port diaphragm displacement pump prototypes were fabricated as designed. The bench study showed that the single port pulsatile VAD achieved a pumping flow of up to 3.75 L/min. Valve regurgitation was <3%. In the sheep study, the valved single lumen cannula was easily installed within 1 min at first attempt. The single port pulsatile VAD achieved maximal 3.75 L/min pumping flow in a 52 kg sheep. The single port pulsatile VAD had consistent pumping flow through 6 hrs with stable hemodynamics (Table). Hemoglobin and platelet/white blood cell counts were unchanged. No obvious injury or thrombosis in heart or single port pulsatile VAD were observed at necropsy. Conclusions: Our single port pulsatile VAD only requires a single apex cannulation with valved single lumen cannula to achieve reliable LVAD performance, showing great promise for a short to mid-term minimally invasive LVAD.Figure 1. Our single port pulsatile ventricular assist device with a valved single lumen cannula and a valveless single port diaphragm displacement pump. Table 1. - Hemodynamics and Blood Count Results Sheep 1-5 Baseline Pump Run1 hr Pump Run3 hr Pump Run6 hr sABP (mm Hg) 111±15.5 138±19.5 122±16.4 113±16.2 CVP (mm Hg) 11±0.4 11±0.8 11±0.5 11±0.8 CO (L/min) 2.5±0.38 3.8±0.98 3.6±0.66 3.5±0.66 Pump Flow (L/min) 0±0 2.8±0.65* 2.7±0.65* 2.7±0.52* HR (bpm) 154±61.1 104±44.7 105±39.3 127±16 WBC (103/uL) 4.1±0.14 N/A N/A 4.8±2.57 PLT (103/uL) 467±93.3 N/A N/A 380±171 HgB (g/dL) 9.4±0.45 N/A N/A 9.1±0.38 * p<0.05 vs Baseline sABP=systolic arterial pressure, CVP=central venous pressure, CO=cardiac output, HR=heart rate, WBC=white blood cell count, PLT=platelet count, HgB=hemoglobin, and N/A=not applicable.

Impact of compressed sensing (CS) acceleration of two-dimensional (2D) flow sequences in clinical paediatric cardiovascular magnetic resonance (CMR)

ObjectivesTwo-dimensional (2D) through-plane phase-contrast (PC) cine flow imaging assesses shunts and valve regurgitations in paediatric CMR and is considered the reference standard for Clinical quantification of blood Flow (COF). However, longer breath-holds (BH) can reduce compliance with possibly large respiratory manoeuvres altering flow. We hypothesize that reduced BH time by application of CS (Short BH quantification of Flow) (SBOF) retains accuracy while enabling faster, potentially more reliable flows. We investigate the variance between COF and SBOF cine flows.MethodsMain pulmonary artery (MPA) and sinotubular junction (STJ) planes were acquired at 1.5 T in paediatric patients by COF and SBOF.Results21 patients (mean age 13.9, 10–17y) were enrolled. The BH times were COF mean 11.7 s (range 8.4–20.9 s) vs SBOF mean 6.5 s (min 3.6–9.1 s). The differences and 95% CI between the COF and SBOF flows were LVSV -1.43 ± 13.6(ml/beat), LVCO 0.16 ± 1.35(l/min) and RVSV 2.95 ± 12.3(ml/beat), RVCO 0.27 ± 0.96(l/min), QP/QS were SV 0.04 ± 0.19, CO 0.02 ± 0.23. Variability between COF and SBOF did not exceed intrasession variation of COF.ConclusionSBOF reduces breath-hold duration to 56% of COF. RV flow by SBOF was biased compared to COF. The variation (95% CI) between COF and SBOF was similar to the COF intrasession test–retest 95% CI.

The effects of leaflet material properties on the simulated function of regurgitant mitral valves

Advances in three-dimensional imaging provide the ability to construct and analyze finite element (FE) models to evaluate the biomechanical behavior and function of atrioventricular valves. However, while obtaining patient-specific valve geometry is now possible, non-invasive measurement of patient-specific leaflet material properties remains nearly impossible. Both valve geometry and tissue properties play a significant role in governing valve dynamics, leading to the central question of whether clinically relevant insights can be attained from FE analysis of atrioventricular valves without precise knowledge of tissue properties. As such we investigated (1) the influence of tissue extensibility and (2) the effects of constitutive model parameters and leaflet thickness on simulated valve function and mechanics. We compared metrics of valve function (e.g., leaflet coaptation and regurgitant orifice area) and mechanics (e.g., stress and strain) across one normal and three regurgitant mitral valve (MV) models with common mechanisms of regurgitation (annular dilation, leaflet prolapse, leaflet tethering) of both moderate and severe degree. We developed a novel fully-automated approach to accurately quantify regurgitant orifice areas of complex valve geometries. We found that the relative ordering of the mechanical and functional metrics was maintained across a group of valves using material properties up to 15% softer than the representative adult mitral constitutive model. Our findings suggest that FE simulations can be used to qualitatively compare how differences and alterations in valve structure affect relative atrioventricular valve function even in populations where material properties are not precisely known.

Twenty-five Years of Root Remodeling for Root Aneurysm and Tricuspid Aortic Valve.

The aim of this retrospective study was to assess the long-term results of root remodelling with tricuspid aortic valves and the effects of concomitant cusp repair and annuloplasty. Between 10/1995 and 12/2021, 684 patients with root aneurysm and regurgitant tricuspid valves were treated by root remodelling. Mean age was 56.5(SD: 14) years, 538(77.6%) were male. Relevant aortic regurgitation was present in 68.3%. Concomitant procedures were performed in 374 patients. The long-term results were analyzed. Mean follow-up of 7.2(SD: 5.3) years (median 6.6 years); it was 95% complete (4934.4 patient-years). Cusps prolapse was repaired in 83%, an annuloplasty was added in 353 instances (51.6%). Hospital mortality was 2.3%, survival was 81.7% (SD: 1.2) and 55.7 (SD: 5.8) at 10 and 20 years; age and measurement of effective height were independent predictors for death.Freedom from AI II was 90.5 (SD : 1.9) at 10 years and 76.7(SD : 4.5) at 20 years. Cusp repair of all cusps showed a lower freedom from recurrent AI≥II at 10 years(p < 0.001). Suture annuloplasty showed a lower freedom from recurrent AI II at 10 years (p = 0.07).Freedom from reoperation was 95.5(SD : 1.1) and 92.8(SD: 2.8) at 10 and 20 years. The addition of an annuloplasty showed no difference(p = 0.236). Cusp repair had no effect on valve durability(p = 0.390). Root remodelling leads to good long-term stability. The addition of cusp repair improves the valve stability over time. The addition of suture annuloplasty improve early valve competency; it showed no effect on freedom from reoperation up to 10 years.

Natural History of Truncal Root Dilatation and Truncal Valve Regurgitation in Truncus Arteriosus

BackgroundThe natural history of the dilated truncal root in repaired truncus arteriosus (TA) is incompletely understood. MethodsA single-center review of patients who underwent TA repair between January 1984 and December 2018 was performed. Echocardiographically determined root diameters and derived z scores were measured at the annulus, sinus of Valsalva (SoV), and sinutubular junction (STJ) immediately before TA repair and throughout follow-up. Linear mixed-effects models assessed trends in root dimensions over time. ResultsOf 193 patients who underwent TA repair at a median age of 12 days (interquartile range, 6-48 days) and survived to discharge, 34 (17.6%), 110 (57.0%), and 49 (25.4%) patients had bicuspid, tricuspid, and quadricuspid truncal valves, respectively. Median postoperative follow-up was 11.6 years (interquartile range, 4.4-22.0 years; range, 0.1-34.8 years). Truncal valve or root intervention was required in 38 patients (19.7%). The mean rates of annular, SoV, and STJ growth were 0.7 ± 0.3 mm/y, 0.8 ± 0.5 mm/y, and 0.9 ± 0.4 mm/y, respectively. Root z scores remained stable with time. At baseline, compared with patients with tricuspid leaflet anatomy, bicuspid patients had larger diameters at the SoV (P = .003) and STJ (P = .029), whereas quadricuspid patients had larger STJ diameters (P = .004). Over time, the bicuspid and quadricuspid cohorts demonstrated comparatively greater annular dilatation (both P < .05). Patients with ≥75th percentile root growth rates had a higher incidence of moderate-severe truncal regurgitation (P = .019) and truncal valve intervention (P = .002). ConclusionsRoot dilatation in TA persisted for up to 30 years after primary repair. Patients with bicuspid and quadricuspid truncal valves demonstrated greater root dilatation over time and required more valve interventions. Continued longitudinal follow-up is warranted in this higher-risk cohort.

Palliative Procedures for Congenital Heart Disease: Imaging Findings and Complications

Palliative procedures are performed for congenital heart diseases that are not amenable for definitive surgical procedures or as a component of hybrid procedures along with transcatheter interventions. Multimodality imaging plays an important role in the follow-up of these palliative procedures, mainly for the timely detection of complications and for planning any subsequent palliative or definitive procedure. Echocardiography is the first-line imaging modality, with CT and MRI used as complementary techniques in indeterminate cases. MRI provides anatomic, functional, flow, and tissue characterization information. CT is performed for the evaluation of vascular anatomy and when MRI cannot be performed due to contraindications, challenges, or artifacts. The modified Blalock-Taussig shunt procedure is the most common systemic-pulmonary artery (PA) shunt procedure, with thrombus being the most serious complication. Other complications of systemic-PA shunts include shunt stenosis, infection, pulmonary overcirculation, and cardiac failure. The Glenn shunt procedure is the second stage of palliation in single ventricle physiology, with thrombus, stenosis, superior vena cava syndrome, and infection being the common complications. The Fontan shunt procedure is the third stage of palliation in single ventricle physiology. Complications can be cardiovascular (heart failure, valve regurgitation, thromboembolism, shunt stenosis, arteriovenous malformation), venolymphatic (collaterals, protein-losing enteropathy, plastic bronchitis), or hepatic (congestion, cirrhosis, portal hypertension). PA banding is used to decrease pulmonary flow or to train the systemic ventricle. Complications include stenosis, thrombus, erosion, pseudoaneurysm, and subaortic obstruction. Atrial septostomy and atrial switch procedures are performed for increasing intracardiac mixing. Complications of atrial septostomy can be mechanical, traumatic, embolic, or electrical. Complications of the atrial switch procedure include baffle stenosis, baffle leak, and systemic ventricle failure. The authors review the role of multimodality imaging in the evaluation of these palliative procedures. © RSNA, 2023 See the invited commentary by Bardo and Popescu in this issue. Quiz questions for this article are available through the Online Learning Center.